Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-27

Clinical Trial Update: Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD [NA]

View source ↗

Summary

This document reports that the dNerva Lung Denervation System is being evaluated for safety and efficacy in patients with COPD, with recruitment currently ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • dNerva Lung Denervation System

Snippet

Sponsor: Nuvaira, Inc. | Conditions: COPD, Chronic Obstructive Pulmonary Disease | NA | Status: RECRUITING